Plus Therapeutics, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
PSTV on Nasdaq
Location
4200 Marathon Blvd., Suite 200, Austin, TX

Insiders trading volume in the past year

Plus Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Marc H. Hedrick Chief Executive Officer, Director $84.6K Oct 1, 2025
Robert P. Lenk Director $68.1K +$53.8K +375% Aug 22, 2025
Greg Petersen Director $66K Feb 18, 2025
Howard Clowes Director $35.4K Aug 13, 2025
Richard J. Hawkins Director $22.8K Aug 13, 2025
Andrew Sims Chief Financial Officer $22.6K Oct 1, 2025
Kyle Guse Director $0 Aug 13, 2025
An van Es-Johansson Director Aug 13, 2025
Norman D. LaFrance Chief Medical Officer Feb 22, 2024

Recent Insider Transactions by Companies or Individuals for Plus Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.